2023
DOI: 10.1016/j.omtn.2023.04.028
|View full text |Cite
|
Sign up to set email alerts
|

Modified ASO conjugates encapsulated with cytidinyl/cationic lipids exhibit more potent and longer-lasting anti-HCC effects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 58 publications
0
1
0
Order By: Relevance
“…30 In addition, modified antisense nucleic acids G3139 and CT102 encapsulated by cytidinyl-lipid/cationic lipid (DNCA/CLD) were able to enter cells, and a high proportion of nuclear colocalization was observed. 31,32…”
Section: Introductionmentioning
confidence: 99%
“…30 In addition, modified antisense nucleic acids G3139 and CT102 encapsulated by cytidinyl-lipid/cationic lipid (DNCA/CLD) were able to enter cells, and a high proportion of nuclear colocalization was observed. 31,32…”
Section: Introductionmentioning
confidence: 99%